These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3773196)

  • 41. Papanicolaou smear screening interval and risk of cervical cancer.
    Shy K; Chu J; Mandelson M; Greer B; Figge D
    Obstet Gynecol; 1989 Dec; 74(6):838-43. PubMed ID: 2586947
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical evaluation of the Pap smear and the importance of followup.
    Lash AF
    IMJ Ill Med J; 1969 Apr; 135(4):408-11 passim. PubMed ID: 4388495
    [No Abstract]   [Full Text] [Related]  

  • 43. Observations from the CDC. An assessment of Pap smears and hysterectomies among women in the United States.
    Saraiya M; Lee NC; Blackman D; Smith MJ; Morrow B; McKenna MT
    J Womens Health Gend Based Med; 2002 Mar; 11(2):103-9. PubMed ID: 11975858
    [No Abstract]   [Full Text] [Related]  

  • 44. Value of the Papanicolaou smear and biopsy as diagnostic aids in pregnancy.
    PECKHAM B; CHUNG J
    Clin Obstet Gynecol; 1958 Sep; 1(3):703-8. PubMed ID: 13608928
    [No Abstract]   [Full Text] [Related]  

  • 45. Appraisal of the modalities used to evaluate an initial abnormal Papanicolaou smear.
    Higgins RV; Hall JB; McGee JA; Laurent S; Alvarez RD; Partridge EE
    Obstet Gynecol; 1994 Aug; 84(2):174-8. PubMed ID: 8041525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cervical smears unsuitable for exclusion of cervical carcinoma].
    Giard RW; Blok P
    Ned Tijdschr Geneeskd; 2000 Jan; 144(2):86-7. PubMed ID: 10674109
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Value of wet mount and cervical cultures at the time of cervical cytology in asymptomatic women.
    Eltabbakh GH; Eltabbakh GD; Broekhuizen FF; Griner BT
    Obstet Gynecol; 1995 Apr; 85(4):499-503. PubMed ID: 7898823
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of and attitudes and knowledge about pap smears among women in Kuwait.
    El-Hammasi K; Samir O; Kettaneh S; Al-Fadli A; Thalib L
    J Womens Health (Larchmt); 2009 Nov; 18(11):1825-32. PubMed ID: 19951218
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The evaluation of cervical cancer screening by combining speculoscopy with Papanicolaou smear examination in Taiwan.
    Chang JI; Ou CH; Wu KM; Chen CC; Cheng KC
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Sep; 65(9):430-4. PubMed ID: 12433029
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Papanicolaou smear in private practice.
    FENING W
    Obstet Gynecol; 1957 Dec; 10(6):646-50. PubMed ID: 13484174
    [No Abstract]   [Full Text] [Related]  

  • 51. A comparison of the Papanicolaou smear and the cervigram: sensitivity, specificity, and cost analysis.
    Tawa K; Forsythe A; Cove JK; Saltz A; Peters HW; Watring WG
    Obstet Gynecol; 1988 Feb; 71(2):229-35. PubMed ID: 3336558
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Papanicolaou test for cervical cancer detection. A triumph and a tragedy.
    Koss LG
    JAMA; 1989 Feb; 261(5):737-43. PubMed ID: 2642983
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Study points to value of HPV screening for cervical cancer: test may be viable alternative to Pap test.
    Printz C
    Cancer; 2014 Dec; 120(23):3589-90. PubMed ID: 25410486
    [No Abstract]   [Full Text] [Related]  

  • 54. "Litigation cells" in the Papanicolaou smear: extramural review of smears by "experts".
    Frable WJ
    Arch Pathol Lab Med; 1997 Mar; 121(3):292-5. PubMed ID: 9111121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Automated rescreening of Papanicolaou smears: what are the implications?
    Birdsong GG
    Diagn Cytopathol; 1995 Nov; 13(4):283-6. PubMed ID: 8599909
    [No Abstract]   [Full Text] [Related]  

  • 56. Comparison of a self-administered tampon ThinPrep test with conventional pap smears for cervical cytology.
    Budge M; Halford J; Haran M; Mein J; Wright G
    Aust N Z J Obstet Gynaecol; 2005 Jun; 45(3):215-9. PubMed ID: 15904447
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Value of conventional cervical cytology as a screening test for cervical cancer.
    Marahatta Khanal R
    Nepal Med Coll J; 2014 Sep; 16(1):63-7. PubMed ID: 25799815
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The coverage of cervical screening in Hungary].
    Boncz I; Sebestyén A; Döbrossy L; Kovács A; Budai A; Székely T
    Orv Hetil; 2007 Nov; 148(46):2177-82. PubMed ID: 17988975
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Women getting regular care may prefer Pap tests for cancer screening.
    Perspect Sex Reprod Health; 2015 Jun; 47(2):110. PubMed ID: 26095737
    [No Abstract]   [Full Text] [Related]  

  • 60. The management of patients with a positive Papanicolaou smear.
    SWINTON NW; LEHMAN G
    Surg Clin North Am; 1959 Jun; 39(3):825-30. PubMed ID: 13659397
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.